Copyright
©The Author(s) 2024.
World J Diabetes. May 15, 2024; 15(5): 935-944
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.935
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.935
Figure 4 A comparison of 3 Screen Islet Cell Autoantibody titers between patients with Graves’ disease and Hashimoto’s thyroiditis in each group.
There was no significant difference in 3 Screen Islet Cell Autoantibody titer regarding Graves’ disease and Hashimoto’s thyroiditis in any of the groups. AITD: Autoimmune thyroid disease; T1D: Type 1 diabetes; T2D: Type 2 diabetes; Graves: Graves’ disease; Hashimoto: Hashimoto’s thyroiditis; 3 Screen ICA: 3 Screen Islet Cell Autoantibody.
- Citation: Kawasaki E, Tamai H, Fukuyama T, Sagara Y, Hidaka R, Uchida A, Tojikubo M, Tatsumoto N, Akehi Y, Hiromatsu Y. Enzyme-linked immunosorbent assay of 3 Screen Islet Cell Autoantibody in patients with autoimmune thyroid disease. World J Diabetes 2024; 15(5): 935-944
- URL: https://www.wjgnet.com/1948-9358/full/v15/i5/935.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i5.935